{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T21:45:58Z","timestamp":1786139158214,"version":"build-2736575974"},"reference-count":0,"publisher":"American Society of Hematology","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>The clinical successes of chimeric antigen receptor (CAR) T cells represent a major shift in immunotherapy. However, there is also increasing emphasis on potential long-term effects of CAR T cell therapy, especially using preclinical xenogeneic models. It has been previously demonstrated that only na\u00efve, and not memory, peripheral blood human T cells can mediate a rapid and acute xenogeneic graft-versus-host disease (xenoGVHD). Here, we demonstrate that simply by altering the donor T cells in the process of generating CAR T cells, in which they are all memory phenotype, that the xenoGVHD outcome was markedly altered. Following tumor clearance with CAR T cell administration, we observed a significantly delayed (up to 200 days post-transfer with some donors) occurrence of lethal xenoGVHD, marked by profound scleroderma and multi-organ pathology consistent with chronic, not acute, GVHD. Notably, this novel chronic xenoGVHD occurred in the absence of B cells, which are classically associated with mediating chronic GVHD pathology. TCR-repertoire constriction during disease and the lack of disease using MHCI\/II double-knockout NSG recipient mice confirmed the observed pathology was xenoGVHD and mediated by human-TCR:murine-MHC interactions. Interestingly, despite the consistent expansion of CAR-positive T cells during early tumor-clearance, a later emergence of CAR-negative populations during xenoGVHD also resulted. Our findings highlight xenoGVHD as a problem that makes long-term assessment of CAR T efficacy or toxicity highly problematic in xenograft models due to the artefact of xenoreactivity which is not representative of autologous clinical usage, and the profound effect that T cell alterations have in GVHD pathophysiology.<\/jats:p>","DOI":"10.1182\/bloodadvances.2025019559","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:54:28Z","timestamp":1786136068000},"update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Chronic xenogeneic GVHD after CAR T cell therapy limits long-term safety assessment of CAR effects using NSG mouse model"],"prefix":"10.1182","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3798-3818","authenticated-orcid":false,"given":"Wahed A.","family":"Firoz","sequence":"first","affiliation":[{"name":"UC Davis School of Medicine, Sacramento, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Sheng","sequence":"additional","affiliation":[{"name":"UC Davis School of Medicine, Sacramento, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Ruivo","sequence":"additional","affiliation":[{"name":"UC Davis School of Veterinary Medicine, Davis, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9778-0120","authenticated-orcid":false,"given":"Logan Vahid","family":"Vick","sequence":"additional","affiliation":[{"name":"UC Davis School of Medicine, Sacramento, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig P.","family":"Collins","sequence":"additional","affiliation":[{"name":"UC Davis School of Medicine, Sacramento, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan N.","family":"Nielsen","sequence":"additional","affiliation":[{"name":"UC Davis School of Medicine, Sacramento, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2802-1543","authenticated-orcid":false,"given":"Ravi K.","family":"Shah","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin, Milwaukee, Wisconsin, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lam T.","family":"Khuat","sequence":"additional","affiliation":[{"name":"University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7412-1727","authenticated-orcid":false,"given":"Ying","family":"Xiong","sequence":"additional","affiliation":[{"name":"Caring Cross, Gaithersburg, Maryland, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneesh","family":"Dave","sequence":"additional","affiliation":[{"name":"UC Davis School of Medicine, Sacramento, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Judge","sequence":"additional","affiliation":[{"name":"UC Davis School of Medicine, Sacramento, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Canter","sequence":"additional","affiliation":[{"name":"UC Davis School of Medicine, Sacramento, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5175-8004","authenticated-orcid":false,"given":"Arta M.","family":"Monjazeb","sequence":"additional","affiliation":[{"name":"UC Davis Health, Sacramento, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9608-9841","authenticated-orcid":false,"given":"Bruce R.","family":"Blazar","sequence":"additional","affiliation":[{"name":"University of Minnesota, Minneapolis \/ MN \/ 55455, Minnesota, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5712-5339","authenticated-orcid":false,"given":"Anthony Elston","family":"Zamora","sequence":"additional","affiliation":[{"name":"UC Davis School of Medicine, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2793-401X","authenticated-orcid":false,"given":"William J.","family":"Murphy","sequence":"additional","affiliation":[{"name":"UC Davis School of Medicine, Sacramento, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,8,7]]},"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/doi\/10.1182\/bloodadvances.2025019559\/2537390\/bloodadvances.2025019559.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/doi\/10.1182\/bloodadvances.2025019559\/2537390\/bloodadvances.2025019559.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:54:28Z","timestamp":1786136068000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/doi\/10.1182\/bloodadvances.2025019559\/570084\/Chronic-xenogeneic-GVHD-after-CAR-T-cell-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025019559","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"article-number":"bloodadvances.2025019559"}}